Lv1
10 积分 2025-06-29 加入
Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now
5小时前
已完结
Targeting inflammation to treat diabetic kidney disease: the road to 2030
5小时前
已完结
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
13小时前
已完结
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
1天前
已完结
皖公网安备34019202002308
